STYZEPIX Trademark

Trademark Overview

On Wednesday, October 17, 2018, a trademark application was filed for STYZEPIX with the United States Patent and Trademark Office. The USPTO has given the STYZEPIX trademark a serial number of 88158566. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 13, 2022. This trademark is owned by Glaxo Group Limited. The STYZEPIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
styzepix

General Information

Serial Number88158566
Word MarkSTYZEPIX
Filing DateWednesday, October 17, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 13, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, June 13, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 13, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 25, 2021SOU EXTENSION 5 GRANTED
Wednesday, October 6, 2021SOU EXTENSION 5 FILED
Friday, October 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 13, 2021SOU EXTENSION 4 GRANTED
Tuesday, April 13, 2021SOU EXTENSION 4 FILED
Tuesday, April 13, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2020SOU EXTENSION 3 GRANTED
Wednesday, September 30, 2020SOU EXTENSION 3 FILED
Wednesday, September 30, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, February 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2020SOU EXTENSION 2 GRANTED
Monday, February 17, 2020SOU EXTENSION 2 FILED
Tuesday, February 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 17, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2019SOU EXTENSION 1 GRANTED
Friday, November 1, 2019SOU EXTENSION 1 FILED
Friday, November 1, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, May 7, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 28, 2019ASSIGNED TO EXAMINER
Monday, October 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 20, 2018NEW APPLICATION ENTERED

Related Keywords

styzepix pharmaceutical treatment preparations diseases disorders substances respiratory oncological genitourinary neurological